Sudhir Srivastava
Sudhir Srivastava
Sudhir Srivastava, PhD, MPH, is chief of the Cancer Biomarkers Research Group of the Division of Cancer Prevention at the United States NCI. Srivastava has held this position since 2000. He is a co-author of the Bethesda Guidelines for the diagnosis of Hereditary non-polyposis colorectal cancer...
blood replace
This is exciting. This could replace the fecal occult blood test.
alone dollars due false millions positive results spent using
Using PSA alone results in millions of dollars being spent on prostate biopsies due to false positive results.
analyze banks cancer candidates power
With the power of bioinformatics, we now have banks of cancer genes. We can analyze them and look for candidates in other cancers.
cancer
We need biomarkers that tell us how the cancer will behave.